Craig Collard | executive |
Ira Duarte | executive |
Serge Belanger | analyst |
Carl Byrnes | analyst |
Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 Conference Call. I would now like to welcome Melissa Dorel, Executive Director, Legal to begin the call. Melissa, over to you.
Thank you, operator, and good afternoon to everyone. Thank you for joining us on the Heron Therapeutics conference call this afternoon to discuss the company's financial results for the fourth quarter ended December 31, 2023.